William H Riffee

William H Riffee,

Dean And Professor Emeritus

Department: Dean's Office
Business Email: riffee@cop.ufl.edu

Publications

2009
Roles of innovation in education delivery.
American journal of pharmaceutical education. 73(8) [PMID] 20221347.
View on: PubMed
1990
Behavioral sensitization following a single apomorphine pretreatment–selective effects on the dopamine release process.
Brain research. 528(1):109-13 [PMID] 2147118.
View on: PubMed
1990
Behavioral sensitization following subchronic apomorphine treatment–possible neurochemical basis.
Brain research. 526(1):37-44 [PMID] 2150341.
View on: PubMed
1988
Apomorphine fails to inhibit cocaine-induced behavioral hypersensitivity.
Pharmacology, biochemistry, and behavior. 29(2):239-42 [PMID] 3362918.
View on: PubMed
1987
Inhibition of amphetamine-induced locomotor activity by S-(+)-apomorphine: comparison with the action of R-(-)-apomorphine.
The Journal of pharmacy and pharmacology. 39(1):71-2 [PMID] 2880993.
View on: PubMed
1987
Prevention of amphetamine-induced behavioral hypersensitivity by concomitant treatment with microgram doses of apomorphine.
European journal of pharmacology. 135(2):255-8 [PMID] 3582497.
View on: PubMed
1986
Dopamine uptake during fast-phase endogenous dopamine release from mouse striatal synaptosomes.
Neuroscience letters. 71(1):106-12 [PMID] 3785732.
View on: PubMed
1985
Comparison between locomotor activity changes produced by phencyclidine and D-amphetamine in CD-1 male mice.
Research communications in chemical pathology and pharmacology. 48(2):189-202 [PMID] 4023408.
View on: PubMed
1985
Effects of multiple pretreatment with apomorphine and amphetamine on amphetamine-induced locomotor activity and its inhibition by apomorphine.
Psychopharmacology. 85(1):97-101 [PMID] 3920704.
View on: PubMed
1984
Effects of ascorbate on a dopaminergic response: apomorphine-induced modification of pentylenetetrazol-induced seizures in mice.
Psychopharmacology. 83(1):48-50 [PMID] 6429699.
View on: PubMed
1982
Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
Psychopharmacology. 77(2):146-9 [PMID] 6812131.
View on: PubMed
1981
Apomorphine: bioavailability and effect on stereotyped cage climbing in mice.
Journal of pharmaceutical sciences. 70(10):1144-7 [PMID] 7197717.
View on: PubMed
1981
Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice.
Psychopharmacology. 75(4):391-5 [PMID] 6803286.
View on: PubMed
1980
Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity.
Pharmacology, biochemistry, and behavior. 12(1):29-33 [PMID] 7189285.
View on: PubMed
1980
Behavioral facilitation following chronic administration of N-n-propylnorapomorphine.
Psychopharmacology. 72(1):113-5 [PMID] 6781003.
View on: PubMed
1980
Hypothermic effects of N-n-propylnorapomorphine in mice: antagonism by neurotransmitter receptor blockers.
Psychopharmacology. 68(1):85-8 [PMID] 6104842.
View on: PubMed
1980
Polydimethylsiloxane pellets for sustained delivery of morphine in mice.
Journal of pharmaceutical sciences. 69(8):980-2 [PMID] 7400953.
View on: PubMed
1980
Stability of apomorphine in solutions containing ascorbic acid and bisulfite and effects of antioxidants on apomorphine-induced cage climbing and hypothermia in mice.
Journal of pharmaceutical sciences. 69(8):974-6 [PMID] 7400950.
View on: PubMed
1980
Strain differences in dopamine receptor function and the initiation of movement.
Pharmacology, biochemistry, and behavior. 13(1):5-7 [PMID] 7403220.
View on: PubMed
1979
Modification of drug-induced behavioral arousal by preinjection routines in mice.
Psychopharmacology. 63(1):1-5 [PMID] 112614.
View on: PubMed
1979
Pharmacological basis for N-n-propylnorapomorphine induced stereotypic cage climbing and behavioral arousal in mice.
Pharmacology, biochemistry, and behavior. 11(6):653-9 [PMID] 43980.
View on: PubMed
1979
Plasma levels of apomorphine following intravenous, intraperitoneal and oral administration to mice and rats.
Research communications in chemical pathology and pharmacology. 24(3):483-99 [PMID] 582213.
View on: PubMed
1979
Stereotypic and hypothermic effects of apomorphine and N-n-propylnorapomorphine in mice.
European journal of pharmacology. 54(3):273-7 [PMID] 570924.
View on: PubMed
1979
Videotaping: the evaluation of stereotypic effects of antiparkinsonian agents.
Pharmacology, biochemistry, and behavior. 10(1):161-4 [PMID] 571607.
View on: PubMed
1978
Brain and plasma concentrations of amphetamine isomers in mice.
The Journal of pharmacology and experimental therapeutics. 206(3):586-94 [PMID] 702323.
View on: PubMed
1978
Comparison of behavioral arousal induced by apomorphine and N-n-propylnorapomorphine.
Research communications in chemical pathology and pharmacology. 22(2):301-12 [PMID] 569888.
View on: PubMed
1977
Acute and chronic effects of (-)-amphetamine on seizure threshold and brain catecholamines in mice.
Biochemical pharmacology. 26(8):799-801 [PMID] 856211.
View on: PubMed
1977
The effects of chronic administration and withdrawal of (+)-amphetamine on seizure threshold and endogenous catecholamine concentrations and their rates of biosynthesis in mice.
Psychopharmacology. 51(2):175-9 [PMID] 402670.
View on: PubMed
1976
Determination of endogenous concentrations of norepinephrine and dopamine and their rates of synthesis in a single mouse brain: biphasic effects of (+)-amphetamine.
Archives internationales de pharmacodynamie et de therapie. 219(1):70-8 [PMID] 1267543.
View on: PubMed
1976
Effects of amphetamine isomers and CNS catecholaminergic blockers on seizures in mice.
Neuropharmacology. 15(11):677-82 [PMID] 1036761.
View on: PubMed
1973
Acute and chronic effects of d- and 1-amphetamine on seizure susceptibility in mice.
European journal of pharmacology. 21(3):323-30 [PMID] 4708070.
View on: PubMed

Patents

Issued October 2001
Clinical Practice Assessment Experimental Program Guidebook
#TXu 1-016-592

Teaching Profile

Courses Taught
2012
PHA5517 Pharmacol Bas Ther 2

Contact Details

Emails:
Business:
riffee@cop.ufl.edu